Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL12P31 (Ribosomal protein L12 pseudogene 31) is a human pseudogene listed in several gene catalogs[2]. Pseudogenes are segments of DNA that resemble functional genes but are typically non-functional due to mutations, truncations, or lack of regulatory elements; they generally do not produce a protein or have known biological activity[2]. RPL12P31 is related by sequence to the ribosomal protein L12 family. The functional ribosomal protein L12 is a component of the large ribosomal 60S subunit active in protein synthesis, but RPL12P31 itself does not encode a functional ribosomal protein and has no established function in humans[2]. There is no evidence that RPL12P31 is a receptor, enzyme, transporter, or otherwise druggable target, nor does it have established roles in cellular processes, disease, or as a biomarker. It is not discussed in therapeutic contexts and is not a focus of pharmacological intervention[2]. RPL12P31 is one of many human ribosomal protein L12 pseudogenes; the functional gene in this family is RPL12 (encodes Ribosomal protein L12), which should not be confused with RPL12P31[5][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L12 pseudogene 31 (RPL12P31).